These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28759861)

  • 1. Concurrent hyperadrenocorticism and diabetes mellitus in dogs.
    Miceli DD; Pignataro OP; Castillo VA
    Res Vet Sci; 2017 Dec; 115():425-431. PubMed ID: 28759861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low dose of insulin detemir controls glycaemia, insulinemia and prevents diabetes mellitus progression in the dog with pituitary-dependent hyperadrenocorticism.
    Miceli DD; Gallelli MF; Cabrera Blatter MF; Martiarena B; Brañas MM; Ortemberg LR; Gómez NV; Castillo VA
    Res Vet Sci; 2012 Aug; 93(1):114-20. PubMed ID: 21807392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective evaluation of the effect of trilostane on insulin requirement and fructosamine concentration in eight diabetic dogs with hyperadrenocorticism.
    McLauchlan G; Knottenbelt C; Augusto M; Helm J; McGrotty Y; Ramsey I
    J Small Anim Pract; 2010 Dec; 51(12):642-8. PubMed ID: 21121919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preliminary evaluation of the circulating leptin/adiponectin ratio in dogs with pituitary-dependent hyperadrenocorticism and concurrent diabetes mellitus.
    Kim H; Kang JH; Jung DI; Kang BT; Chang D; Yang MP
    Domest Anim Endocrinol; 2021 Jan; 74():106506. PubMed ID: 32920447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Hypertriglyceridemia as a Mediator Between Endocrine Diseases and Pancreatitis in Dogs.
    Kim H; Kang JH; Heo TY; Kang BT; Kim G; Chang D; Na KJ; Yang MP
    J Am Anim Hosp Assoc; 2019; 55(2):92-100. PubMed ID: 30776262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of renal function assessing serum cystatin C in dogs with diabetes mellitus or hyperadrenocorticism.
    Marynissen SJ; Smets PM; Ghys LF; Paepe D; Delanghe J; Galac S; Meyer E; Lefebvre HP; Daminet S
    Vet Clin Pathol; 2016 Jun; 45(2):320-9. PubMed ID: 27228235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of renal vascular resistance in dogs with diabetes mellitus and hyperadrenocorticism.
    Novellas R; de Gopegui RR; Espada Y
    Vet Rec; 2008 Nov; 163(20):592-6. PubMed ID: 19011245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance in dogs.
    Hess RS
    Vet Clin North Am Small Anim Pract; 2010 Mar; 40(2):309-16. PubMed ID: 20219491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentrations of noncortisol adrenal steroids in response to ACTH in dogs with adrenal-dependent hyperadrenocorticism, pituitary-dependent hyperadrenocorticism, and nonadrenal illness.
    Monroe WE; Panciera DL; Zimmerman KL
    J Vet Intern Med; 2012; 26(4):945-52. PubMed ID: 22708651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum acute phase protein concentrations in dogs with hyperadrenocorticism with and without concurrent inflammatory conditions.
    Caldin M; Tasca S; Carli E; Bianchini S; Furlanello T; Martinez-Subiela S; Cerón JJ
    Vet Clin Pathol; 2009 Mar; 38(1):63-8. PubMed ID: 19228354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between diabetes mellitus, hypothyroidism or hyperadrenocorticism, and atherosclerosis in dogs.
    Hess RS; Kass PH; Van Winkle TJ
    J Vet Intern Med; 2003; 17(4):489-94. PubMed ID: 12892299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal and glucagon-stimulated plasma C-peptide concentrations in healthy dogs, dogs with diabetes mellitus, and dogs with hyperadrenocorticism.
    Montgomery TM; Nelson RW; Feldman EC; Robertson K; Polonsky KS
    J Vet Intern Med; 1996; 10(3):116-22. PubMed ID: 8743209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feline comorbidities: Recognition, diagnosis and management of the cushingoid diabetic.
    Cook AK; Evans JB
    J Feline Med Surg; 2021 Jan; 23(1):4-16. PubMed ID: 33403912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic efficacy of plasma ACTH-measurement by a chemiluminometric assay in canine hyperadrenocorticism].
    Zeugswetter F; Pagitz M; Hittmair K; Schwendenwein I
    Schweiz Arch Tierheilkd; 2011 Mar; 153(3):111-6. PubMed ID: 21360448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of coagulation and potential biochemical markers for hypercoagulability in canine hyperadrenocorticism.
    Pace SL; Creevy KE; Krimer PM; Brainard BM
    J Vet Intern Med; 2013; 27(5):1113-20. PubMed ID: 23952553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the urine cortisol-to-creatinine ratio for monitoring dogs with pituitary-dependent hyperadrenocorticism during induction treatment with mitotane (o,p'-DDD).
    Randolph JF; Toomey J; Center SA; Scarlett JM; Reimers T; Graham P; Nachreiner RF
    Am J Vet Res; 1998 Mar; 59(3):258-61. PubMed ID: 9522940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of canine hyperadrenocorticism on coagulation parameters.
    Rose L; Dunn ME; Bédard C
    J Vet Intern Med; 2013; 27(1):207-11. PubMed ID: 23278831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACTH-independent hyperadrenocorticism due to food-dependent hypercortisolemia in a dog: a case report.
    Galac S; Kars VJ; Voorhout G; Mol JA; Kooistra HS
    Vet J; 2008 Jul; 177(1):141-3. PubMed ID: 17572120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasonographic evaluation of skin thickness in small breed dogs with hyperadrenocorticism.
    Heo S; Hwang T; Lee HC
    J Vet Sci; 2018 Nov; 19(6):840-845. PubMed ID: 29929358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes mellitus, hyperadrenocorticism, and hypothyroidism in a dog.
    Hess RS; Ward CR
    J Am Anim Hosp Assoc; 1998; 34(3):204-7. PubMed ID: 9590447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.